Orthofix Medical (OFIX) Total Non-Current Liabilities (2010 - 2026)
Orthofix Medical (OFIX) posted Total Non-Current Liabilities of $395.3 million for Q1 2026, up 14.6% on a QoQ basis from $344.9 million in Q4 2025, and up 24.06% year-over-year from $318.6 million in Q1 2025.
Orthofix Medical (OFIX) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Orthofix Medical's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $395.3 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 24.06% year-over-year to $395.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $395.3 million (up 24.06% YoY) and the FY2025 annual result came in at $344.9 million, down 7.96% from the prior year.
- Total Non-Current Liabilities was $395.3 million for Q1 2026 at Orthofix Medical, up from $344.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $395.3 million in Q1 2026 and bottomed at $97.1 million in Q3 2022.
- A 5-year average of $261.7 million and a median of $287.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities declined 16.02% — and 2023, when it jumped 209.23%.
- Orthofix Medical's Total Non-Current Liabilities stood at $102.9 million in 2022, then soared by 209.23% to $318.1 million in 2023, then climbed by 17.82% to $374.8 million in 2024, then declined by 7.96% to $344.9 million in 2025, then rose by 14.6% to $395.3 million in 2026.
- Business Quant data shows OFIX's Total Non-Current Liabilities at $395.3 million in Q1 2026, $344.9 million in Q4 2025, and $334.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Orthofix Medical | 443.33 Mn | 322.46 Mn | 139.55 Mn | 395.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 395.31 Mn |
| Dec 31, 2025 | 344.93 Mn |
| Sep 30, 2025 | 334.31 Mn |
| Jun 30, 2025 | 368.81 Mn |
| Mar 31, 2025 | 318.64 Mn |
| Dec 31, 2024 | 374.77 Mn |
| Sep 30, 2024 | 292.14 Mn |
| Jun 30, 2024 | 287.44 Mn |
| Mar 31, 2024 | 284.04 Mn |
| Dec 31, 2023 | 318.09 Mn |
| Sep 30, 2023 | 241.25 Mn |
| Jun 30, 2023 | 254.50 Mn |
| Mar 31, 2023 | 201.64 Mn |
| Dec 31, 2022 | 102.86 Mn |
| Sep 30, 2022 | 97.06 Mn |
| Jun 30, 2022 | 118.72 Mn |
| Mar 31, 2022 | 114.72 Mn |
| Dec 31, 2021 | 122.49 Mn |
| Sep 30, 2021 | 100.05 Mn |
| Jun 30, 2021 | 132.43 Mn |